fbpx
Connect with us

News

Partnership formed to maximise potential of next-gen health tech

Published

on

A global partnership has been formed between CPI and Cambridge Design Partnership to help speed up the delivery of transformative diagnostic and healthcare technologies to patients. 

The partnership aims to maximise the potential of next-generation diagnostic and healthcare technologies, shape the leading edge of innovation into commercial readiness and ultimately ensure UK leadership in medical technologies that transform the healthcare experience.

UK-based CPI is an independent deep-tech innovation centre and founding member of the High Value Manufacturing Catapult. CPI helps drive organisations through their innovation journey, uniting academia, businesses, and investors to accelerate bright ideas and research into the marketplace. 

Now in its 25th year, Cambridge Design Partnership delivers end-to-end product and technology development for clients in the healthcare, consumer, and industrial equipment sectors. 

The partnership builds on the capability of both businesses – CDP gains access to CPI’s specialist expertise and capabilities in development and business scale-up. As a result, it can accelerate its most innovative client projects to market-seeding volumes. 

Projects at CPI benefit from its GMP and ISO13485 certified Quality Management System, ensuring compliance with relevant legislation and standards. 

Together, they will drive future growth, and aim to establish the UK as a world-leading player in diagnostic and healthcare technologies.

The success of the partnership will be measured in terms of commercial and patient impact. The two companies plan to shape early-stage innovation into investment ready business cases and market-ready products. 

This will streamline the development of effective products and technologies, providing value to patients within key clinical areas such as infectious disease and oncology. A particular goal is to maximise the impact of the UK’s scientific and technology research base, improving the path to commercialisation and the clinic.

Arun Harish, director of strategy at CPI, says: “Increasingly, we’re witnessing collaborative approaches to innovation development. Collaboration is at the heart of CPI’s strategy as we continue to serve multiple established and emerging industries. 

“We’re pleased to be partnering with CDP to develop and accelerate diagnostics and healthtech products, where the potential for innovation is immense.”

Cambridge Design Partnership’s senior innovation consultant Pari Datta adds: “The UK has a strong science and technology base, with a history of scientific firsts behind many great products now on the global stage. But we don’t always spot the opportunities or navigate the path to commercialisation, particularly in the regulated medical space. 

“With CPI, we’re working to grow the ecosystem which will discover, nurture and scale these promising businesses, leading to great new products delivering real value to patients, professionals and the UK economy.”

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories